Article 1
Trans-resveratrol as specified in the Annex to this Decision may be placed on the market in the Union as a novel food ingredient to be used in food supplements in capsule or tablet form intended for adult population only with a maximum dose of 150 mg per day without prejudice to the provisions of Directive 2002/46/EC.
Article 2
1.
The designation of trans-resveratrol authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘trans-resveratrol’.
2.
The labelling of food supplements containing trans-resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision.
Article 3
This Decision is addressed to DSM Nutritional Products Ltd, Heanor Gate Ind. Est. Heanor, Derbyshire, United Kingdom.
Done at Brussels, 19 July 2016.
For the Commission
Vytenis Andriukaitis
Member of the Commission